Researchers at the Icahn School of Medicine at Mount Sinai compared the single-cell transcriptomic and proteomic profiles of atherosclerotic plaques between patients with recent cardiovascular events and asymptomatic patients to uncover distinct immune characteristics that may advance the development of precision cardiovascular therapeutics.
Skip to main content
